Report on the Drug Situation 2010 - Bundesministerium für ...

Figure 5.1
Number of people entering drug treatment in 2009, by age and type of service
Number of clients since 2009
1 950
1 800
1 650
1 500
1 350
1 200
1 050
900
750
600
450
300
150
0
56
18
33
6
1 645
1 474
1 259
1213
1 010
957
789
753
701
562
530
442
257 262
160
116 133
138 106 125
14 or younger 15-19 years 20-24 years 25-29 years 30-34 years 35 or older
Short-term contacts (n = 6 233) Low-threshold services (n = 663)
Long-term outpatient treatment (n = 4 187) Long-term inpatient treatment (n = 1 662)
Source: GÖG/ÖBIG 2010a, DOKLI analysis of client year 2009; representation by GÖG/ÖBIG
In the traditional treatment settings (long-term outpatient or inpatient treatment),
opioids predominate as primary drugs 24 . Cocaine continues to be irrelevant as far as
primary drugs are concerned (see Figure 5.2 and Table A26 in Annex A). This shows
that in Austria, different to a number of other countries of the European Union, opioids
24
For compiling the DOKLI case history, clients are first asked to name all drugs they have ever taken. Then the
drugs mentioned are classified according to current patterns of use, as primary drugs, additional drugs, drugs
only taken in the context of experimental use and drugs not relevant for treatment. The primary drug is the
drug which causes the greatest problems from the personal point of view of the client. Here, problems – on the
basis of ICD 10 – are understood as psychosocial and health-related problems and not solely legal problem
situations. As a rule, the primary drug is the drug because of which the client has started the current treatment.
If a client cannot decide which drug is the primary drug, several drugs may be named. Additional drugs are
drugs which the client has used in addition to the primary drug in the past six months and which also constitute
a problem for the client. Experimental drug use refers to intermittent use of the corresponding drug in the past
six months without harmful use or manifest addiction problems. Drug use not relevant for treatment means
that the drug in question has occasionally been taken over a period of more than half a year but no harmful use
or manifest addiction problems show, or that the drug was used in the past but not during the six-month
period preceding treatment (GÖG/ÖBIG 2010a).
Chapter 5 / Drug-related Treatment: Treatment Demand and Treatment Availability 45